電子ドラッグデリバリー装置の世界市場：市場規模・シェア・動向分析 (製品別・用途別・地域別)、セグメント別予測 (2025年～2030年)

電子ドラッグデリバリー装置市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の電子ドラッグデリバリー装置の市場規模は2030年までに995億米ドルに達すると予測され、2025年から2030年までのCAGRは8.14%で成長すると予測されています。

この成長は、高齢者人口の増加と慢性疾患の蔓延、個別化医療に対する意識の高まり、在宅医療の人気拡大、デジタル技術の統合などに起因しています。例えば、2024年6月、AptarGroup, Inc.はSHL Medicalと提携し、Aptar Digital HealthのSaMDプラットフォームをSHL Medicalの自動注射器、ペン型注射器、特殊デリバリーシステムなどの先進ドラッグデリバリーシステムと統合しました。

患者が自宅で健康状態を管理することを好むようになっているため、安全で効果的かつ簡単な自宅治療を可能にするドラッグデリバリー装置に対する需要が高まっています。インスリンポンプ、自動注射器、ウェアラブル輸液ポンプ、プレフィルドシリンジなどのデバイスは、患者が最小限の補助で薬剤を自己投与でき、利便性と自律性の両方を提供できるため、在宅医療に欠かせないツールになりつつあります。例えば、2023年10月、革新的なPEEKバイオマテリアル・ソリューションで知られるVictrex plcは、ドラッグデリバリーや医薬品接触用途向けに特別に設計された先進的な製品、VICTREX PC101グレードを発表しました。この発売は、ドラッグデリバリー機器をホームケア環境で利用する傾向が高まっており、革新的なソリューションを求める患者へのアクセシビリティを高めるものです。

さらに、電子ドラッグデリバリー装置市場の技術動向は、より高い精度、個別化、患者の利便性へのニーズに後押しされ、急速に進展しています。新たな動向としては、デジタルヘルス技術の統合、ウェアラブルドラッグデリバリー装置、マイクロ流体工学の利用などが挙げられます。精密医療の台頭も技術革新を後押ししています。電子薬物送達デバイスは、個人の遺伝的体質、病状、あるいは特定の治療ニーズに合わせて調整され、より良い転帰と副作用の低減を確実なものにしています。

電子ドラッグデリバリー装置市場：分析概要

• 製品別では、埋め込み型ドラッグデリバリー装置が、副作用の軽減、薬物放出の制御、局所的な治療が可能であることから、2024年には33.0%の最大売上シェアで市場を独占しました。
• 用途別では、糖尿病分野が2024年に最大の収益シェアを占めました。これは、糖尿病の高い有病率と患者数の増加、糖尿病治療における技術進歩、市場需要の増加、償還支援によるものです。
• 地域別では、北米が2024年に43.4％超の最大収益シェアを占めました。これは、技術進歩、慢性疾患の有病率の増加、患者中心のドラッグデリバリーソリューションに対する需要の高まりに起因しています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 電子ドラッグデリバリー装置市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 主要な技術動向
• 主要ブランド
• パイプライン分析
• 電子ドラッグデリバリー装置市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 電子ドラッグデリバリー装置市場：製品別の推定・動向分析

• セグメントダッシュボード
• 電子ドラッグデリバリー装置市場：製品別の変動分析
• 電子ドラッグデリバリー装置市場：製品別の展望
• 市場規模の予測と動向分析（2018～2030年）
• スマート輸液ポンプ（輸液システム）
• スマート定量吸入器（吸入装置）
• 埋め込み型ドラッグデリバリー装置

第5章 電子ドラッグデリバリー装置市場：用途別の推定・動向分析

• セグメントダッシュボード
• 電子ドラッグデリバリー装置市場：用途別の変動分析
• 電子ドラッグデリバリー装置市場：用途別の展望
• 市場規模の予測と動向分析（2018～2030年）
• 糖尿病
• 呼吸器疾患
• 腫瘍学
• 心臓病学
• その他

第6章 電子ドラッグデリバリー装置市場：地域別の推定・動向分析

• 地域ダッシュボード
• 電子ドラッグデリバリー装置市場：地域別の変動分析
• 電子ドラッグデリバリー装置市場：地域別の推定・動向分析
• 市場規模の予測と動向分析（2018～2030年）
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Medtronic plc
  • Insulet Corporation
  • Becton, Dickinson and Company
  • Tandem Diabetes Care, Inc.
  • Ypsomed AG
  • Novo Nordisk A/S
  • Sanofi SA
  • Eli, Lilly and Company
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Boehringer Ingelheim International GmbH
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries
  • Phillips-Medisize, LLC
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • Nemera Group
  • SHL Group
  • Owen Mumford
  • Haselmeier AG
  • ICU Medical
  • Hisamitsu Pharmaceutical Co., Inc.
  • Sparsha Pharma International
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Novartis AG
  • AptarGroup, Inc.
  • Teleflex Incorporates
  • Abbott Laboratories

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 4 Global electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 5 North America electronic drug delivery devices market, by region, 2018 - 2030 (Revenue, USD Million)
• Table 6 North America electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 7 North America electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 8 U.S electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 9 U.S electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 10 Canada electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 11 Canada electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 12 Mexico electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 13 Mexico electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 14 Europe electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
• Table 15 Europe electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 16 Europe electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 17 UK electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 18 UK electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 19 Germany electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 20 Germany electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 21 France electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 22 France electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 23 Italy electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 24 Italy electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 25 Spain electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 26 Spain electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 27 Norway electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 28 Norway electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 29 Sweden electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 30 Sweden electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 31 Denmark electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 32 Denmark electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 33 Asia Pacific electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
• Table 34 Asia Pacific electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 35 Asia Pacific electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 36 Japan electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 37 Japan electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 38 China electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 39 China electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 40 India electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 41 India electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 42 Australia electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 43 Australia electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 44 South Korea electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 45 South Korea electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 46 Thailand electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 47 Thailand electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 48 Latin America electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
• Table 49 Latin America electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 50 Latin America electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 51 Brazil electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 52 Brazil electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 53 Argentina electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 54 Argentina electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 55 Middle East & Africa electronic drug delivery devices market, by country, 2018 - 2030 (Revenue, USD Million)
• Table 56 Middle East & Africa electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 57 Middle East & Africa electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 58 South Africa electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 59 South Africa electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 60 Saudi Arabia electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 61 Saudi Arabia electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 62 UAE electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 63 UAE electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)
• Table 64 Kuwait electronic drug delivery devices market, by product, 2018 - 2030 (Revenue, USD Million)
• Table 65 Kuwait electronic drug delivery devices market, by application, 2018 - 2030 (Revenue, USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Electronic drug delivery devices market segmentation
• Fig. 7 Market driver analysis (Current & future impact)
• Fig. 8 Market restraint analysis (Current & future impact)
• Fig. 9 SWOT Analysis by Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Electronic drug delivery devices market, product outlook key takeaways (Revenue, USD Million)
• Fig. 12 Electronic drug delivery devices market: product movement analysis (Revenue, USD Million), 2023 & 2030
• Fig. 13 Smart infusion pumps (infusion systems) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 14 Non-biologic smart infusion systems market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 15 Biologic smart infusion systems market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 16 Smart infusion insulin pumps market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 17 Others market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 18 Smart metered dose inhalers (inhalation devices) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 19 Implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 20 Biologic implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 21 Non-biologic implantable drug delivery devices market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 22 Smart transdermal patches (transdermal delivery systems) market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 23 Others market revenue estimates and forecasts, 2018 -2030 (Revenue, USD Million)
• Fig. 24 Electronic drug delivery devices market, application outlook key takeaways (Revenue, USD Million)
• Fig. 25 Electronic drug delivery devices market: application movement analysis (Revenue, USD Million), 2023 & 2030
• Fig. 26 Diabetes market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 27 Respiratory Diseases market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 28 Oncology market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 29 Cardiology market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 30 Others market revenue estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 31 Electronic drug delivery devices market: Regional key takeaways (Revenue, USD Million)
• Fig. 32 Electronic drug delivery devices market: regional outlook, 2023 & 2030, (Revenue, USD Million)
• Fig. 33 North America electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 34 US electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 35 Canada electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 36 Mexico electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 37 Europe electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 38 UK electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 39 Germany electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 40 France electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 41 Spain electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 42 Italy electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 43 Sweden electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 44 Norway electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 45 Denmark electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 46 Asia Pacific electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 47 China electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 48 Japan electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 49 India electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million
• Fig. 50 South Korea electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 51 Australia electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 52 Thailand electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 53 Latin America electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 54 Brazil electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 55 Argentina electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 56 Middle East and Africa electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 57 South Africa electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 58 Saudi Arabia electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 59 UAE electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 60 Kuwait electronic drug delivery devices market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 61 List of key emerging company's/technology disruptors/innovators

Electronic Drug Delivery Devices Market Growth & Trends:

The global electronic drug delivery devices market size is anticipated to reach USD 99.5 billion by 2030 and is anticipated to grow at a CAGR of 8.14% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the increasing the growing geriatric population and prevalence of chronic diseases, increasing awareness for personalized medicine, rising preference for home healthcare, and the integration of digital technologies. For instance, in June 2024, AptarGroup, Inc. collaborated with SHL Medical to integrate Aptar Digital Health's SaMD platform with SHL Medical's advanced drug delivery systems, such as autoinjectors, pen injectors, and specialty delivery systems.

As patients are increasingly preferring to manage their health conditions at home, there is a growing demand for drug delivery devices that enable safe, effective, and easy at-home treatments. Devices such as insulin pumps, auto-injectors, wearable infusion pumps, and pre-filled syringes are becoming indispensable tools in home healthcare because they allow patients to self-administer medications with minimal assistance, offering both convenience and autonomy. For instance, in October 2023, Victrex plc, known for its innovative PEEK biomaterial solutions, introduced an advanced product, the VICTREX PC101 grade, specifically designed for drug delivery and pharmaceutical contact applications. This launch aligns with the growing trend of utilizing drug delivery devices in homecare environments, enhancing accessibility for patients seeking innovative solutions.

Moreover, technology trends in the electronic drug delivery devices market are rapidly advancing, driven by the need for greater precision, personalization, and patient convenience. Some of the new trends include the integration of digital health technologies, wearable drug delivery devices, and the use of microfluidics. The rise of precision medicine is also driving innovation. The devices are being tailored to the individual's genetic makeup, condition, or specific therapeutic needs, ensuring better outcomes and fewer side effects.

Electronic Drug Delivery Devices Market Report Highlights:

• Based on product, the implantable drug delivery devices segment dominated the market with the largest revenue share of 33.0% in 2024 owing to reduced side effects, controlled drug release, and their ability to provide localized treatment.
• Based on application, the diabetes segment accounted for the largest revenue share in 2024 due to its high prevalence and growing patient population, technological advancements in diabetes care, growing market demand, and reimbursement support.
• Based on region, North America held the largest revenue share of over 43.4% in 2024. This can be attributed to technological advancements, an increasing prevalence of chronic diseases, and rising demand for patient-centric drug delivery solutions.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Electronic Drug Delivery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases and growing geriatric population
    • 3.2.1.2. Rising preference for home healthcare
    • 3.2.1.3. Integration of digital technologies and growing awareness of personalized medications
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of advanced drug delivery devices
    • 3.2.2.2. Limited patient awareness and device-related complications
• 3.3. Key Technology Trends
• 3.4. Key Brands
• 3.5. Pipeline Analysis
• 3.6. Electronic Drug Delivery Devices Market Analysis Tools
  • 3.6.1. Industry Analysis - Porter's
    • 3.6.1.1. Bargaining power of suppliers
    • 3.6.1.2. Bargaining power of buyers
    • 3.6.1.3. Threat of substitutes
    • 3.6.1.4. Threat of new entrants
    • 3.6.1.5. Competitive rivalry
  • 3.6.2. PESTEL Analysis
    • 3.6.2.1. Political landscape
    • 3.6.2.2. Economic landscape
    • 3.6.2.3. Social landscape
    • 3.6.2.4. Technological landscape
    • 3.6.2.5. Environmental landscape
    • 3.6.2.6. Legal landscape

Chapter 4. Electronic Drug Delivery Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Electronic Drug Delivery Devices Market: Product Movement Analysis
• 4.3. Electronic Drug Delivery Devices Market by Product Outlook (Revenue, USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Smart Infusion Pumps (Infusion Systems)
  • 4.5.1. Smart Infusion Pumps (Infusion Systems) Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.5.1.1. Non-biologic Smart Infusion Systems
      • 4.5.1.1.1. Non-biologic Smart Infusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.5.1.2. Biologic Smart Infusion Systems
      • 4.5.1.2.1. Biologic Smart Infusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
        • 4.5.1.2.1.1. Smart Infusion Insulin Pumps
          • 4.5.1.2.1.1.1. Smart Infusion Insulin Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
        • 4.5.1.2.1.2. Others
          • 4.5.1.2.1.2.1. Others Market Revenue Estimated and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 4.6. Smart Metered Dose Inhalers (Inhalation Devices)
  • 4.6.1. Smart Metered Dose Inhalers (Inhalation Devices) Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 4.7. Implantable Drug Delivery Devices
  • 4.7.1. Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.7.1.1. Biologic Implantable Drug Delivery Devices
      • 4.7.1.1.1. Biologic Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 4.7.1.2. Non-biologic Implantable Drug Delivery Devices
      • 4.7.1.2.1. Non-biologic Implantable Drug Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 5. Electronic Drug Delivery Devices Market: Application Estimated & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Electronic Drug Delivery Devices Market: Application Movement Analysis
• 5.3. Electronic Drug Delivery Devices Market by Application Outlook (Revenue, USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Diabetes
  • 5.5.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.6. Respiratory Diseases
  • 5.6.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.7. Oncology
  • 5.7.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.8. Cardiology
  • 5.8.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Electronic Drug Delivery Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Electronic Drug Delivery Devices Market Movement Analysis
• 6.3. Electronic Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Product
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. Mexico Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.6. Europe
  • 6.6.1. Europe Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. UK Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. Germany Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. France Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. Italy Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Spain Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Denmark Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Reimbursement scenario
    • 6.6.8.5. Sweden Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6.9. Norway
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Competitive Scenario
    • 6.6.9.3. Regulatory Framework
    • 6.6.9.4. Reimbursement scenario
    • 6.6.9.5. Norway Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.2. Japan
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Japan Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. China Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. India Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Reimbursement scenario
    • 6.7.5.5. South Korea Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.6. Australia
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Reimbursement scenario
    • 6.7.6.5. Australia Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key Country Dynamics
    • 6.7.7.2. Competitive Scenario
    • 6.7.7.3. Regulatory Framework
    • 6.7.7.4. Reimbursement scenario
    • 6.7.7.5. Thailand Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.8.2. Brazil
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. Brazil Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Argentina Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
• 6.9. Middle East & Africa
  • 6.9.1. Middle East & Africa Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.9.2. South Africa
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory Framework
    • 6.9.2.4. Reimbursement scenario
    • 6.9.2.5. South Africa Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory Framework
    • 6.9.3.4. Reimbursement scenario
    • 6.9.3.5. Saudi Arabia Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Competitive Scenario
    • 6.9.4.3. Regulatory Framework
    • 6.9.4.4. Reimbursement scenario
    • 6.9.4.5. UAE Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key Country Dynamics
    • 6.9.5.2. Competitive Scenario
    • 6.9.5.3. Regulatory Framework
    • 6.9.5.4. Reimbursement scenario
    • 6.9.5.5. Kuwait Electronic Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Medtronic plc
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Insulet Corporation
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Becton, Dickinson and Company
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Tandem Diabetes Care, Inc.
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Ypsomed AG
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Novo Nordisk A/S
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Sanofi S.A.
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. Eli, Lilly and Company
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. AstraZeneca plc
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. GlaxoSmithKline plc
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. Boehringer Ingelheim International GmbH
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives
  • 7.2.12. Pfizer, Inc.
    • 7.2.12.1. Company overview
    • 7.2.12.2. Financial performance
    • 7.2.12.3. Product benchmarking
    • 7.2.12.4. Strategic initiatives
  • 7.2.13. Teva Pharmaceutical Industries
    • 7.2.13.1. Company overview
    • 7.2.13.2. Financial performance
    • 7.2.13.3. Product benchmarking
    • 7.2.13.4. Strategic initiatives
  • 7.2.14. Phillips-Medisize, LLC
    • 7.2.14.1. Company overview
    • 7.2.14.2. Financial performance
    • 7.2.14.3. Product benchmarking
    • 7.2.14.4. Strategic initiatives
  • 7.2.15. West Pharmaceutical Services, Inc.
    • 7.2.15.1. Company overview
    • 7.2.15.2. Financial performance
    • 7.2.15.3. Product benchmarking
    • 7.2.15.4. Strategic initiatives
  • 7.2.16. Gerresheimer AG
    • 7.2.16.1. Company Overview
    • 7.2.16.2. Financial performance
    • 7.2.16.3. Product benchmarking
    • 7.2.16.4. Strategic initiatives
  • 7.2.17. Nemera Group
    • 7.2.17.1. Company overview
    • 7.2.17.2. Financial performance
    • 7.2.17.3. Product benchmarking
    • 7.2.17.4. Strategic initiatives
  • 7.2.18. SHL Group
    • 7.2.18.1. Company overview
    • 7.2.18.2. Financial performance
    • 7.2.18.3. Product benchmarking
    • 7.2.18.4. Strategic initiatives
  • 7.2.19. Owen Mumford
    • 7.2.19.1. Company overview
    • 7.2.19.2. Financial performance
    • 7.2.19.3. Product benchmarking
    • 7.2.19.4. Strategic initiatives
  • 7.2.20. Haselmeier AG
    • 7.2.20.1. Company overview
    • 7.2.20.2. Financial performance
    • 7.2.20.3. Product benchmarking
    • 7.2.20.4. Strategic initiatives
  • 7.2.21. ICU Medical
    • 7.2.21.1. Company overview
    • 7.2.21.2. Financial performance
    • 7.2.21.3. Product benchmarking
    • 7.2.21.4. Strategic initiatives
  • 7.2.22. Hisamitsu Pharmaceutical Co., Inc.
    • 7.2.22.1. Company overview
    • 7.2.22.2. Financial performance
    • 7.2.22.3. Product benchmarking
    • 7.2.22.4. Strategic initiatives
  • 7.2.23. Sparsha Pharma International
    • 7.2.23.1. Company overview
    • 7.2.23.2. Financial performance
    • 7.2.23.3. Product benchmarking
    • 7.2.23.4. Strategic initiatives
  • 7.2.24. Baxter International, Inc.
    • 7.2.24.1. Company overview
    • 7.2.24.2. Financial performance
    • 7.2.24.3. Product benchmarking
    • 7.2.24.4. Strategic initiatives
  • 7.2.25. Fresenius Kabi AG
    • 7.2.25.1. Company overview
    • 7.2.25.2. Financial performance
    • 7.2.25.3. Product benchmarking
    • 7.2.25.4. Strategic initiatives
  • 7.2.26. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 7.2.26.1. Company overview
    • 7.2.26.2. Financial performance
    • 7.2.26.3. Product benchmarking
    • 7.2.26.4. Strategic initiatives
  • 7.2.27. Novartis AG
    • 7.2.27.1. Company overview
    • 7.2.27.2. Financial performance
    • 7.2.27.3. Product benchmarking
    • 7.2.27.4. Strategic initiatives
  • 7.2.28. AptarGroup, Inc.
    • 7.2.28.1. Company overview
    • 7.2.28.2. Financial performance
    • 7.2.28.3. Product benchmarking
    • 7.2.28.4. Strategic initiatives
  • 7.2.29. Teleflex Incorporates
    • 7.2.29.1. Company overview
    • 7.2.29.2. Financial performance
    • 7.2.29.3. Product benchmarking
    • 7.2.29.4. Strategic initiatives
  • 7.2.30. Abbott Laboratories
    • 7.2.30.1. Company overview
    • 7.2.30.2. Financial performance
    • 7.2.30.3. Product benchmarking
    • 7.2.30.4. Strategic initiatives